Health Cor Management, L.P. Celldex Therapeutics, Inc. Transaction History
Health Cor Management, L.P.
- $106 Million
- Q4 2022
A detailed history of Health Cor Management, L.P. transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Health Cor Management, L.P. holds 255,000 shares of CLDX stock, worth $4.98 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
255,000Holding current value
$4.98 Million% of portfolio
0.19%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding CLDX
# of Institutions
188Shares Held
69.3MCall Options Held
220KPut Options Held
310K-
Wellington Management Group LLP Boston, MA8.35MShares$163 Million0.03% of portfolio
-
Kynam Capital Management, LP Princeton, NJ6.5MShares$127 Million9.94% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$91.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.9MShares$76.1 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.75MShares$73.3 Million1.45% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $913M
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...